The Sumitomo Chemical Group expresses its heartfelt sympathy for all those who have been affected by COVID-19, and for those living in regions where their lives have been affected by its spread, while also expressing its deep respect for the healthcare professionals who work day and night to prevent the spread of the pandemic.
The Sumitomo Chemical Group continues to do its utmost to secure the safety of its employees as its first priority, while meeting its supply responsibilities to customers.
Top Message to All Employees of the Sumitomo Chemical Group
- December 15, 2020
President's Message "To All Members of the Sumitomo Chemical Group"
The message video
- August 6, 2020
President's Message "To the management of overseas Sumitomo Chemical Group companies"
First half of the message video / Second half of the message video
- April 1, 2020
Message from the President for the New Fiscal Year
Infection Prevention Measures in Our Group
April 8, 2020 (To be updated as needed)
About the Response to the Spread of COVID-19
Contributing to Preventing Infectious Disease Spread
- June 1, 2020
Sumitomo Chemical Joins "IP Open Access Declaration Against COVID-19"
- May 8, 2020
Sumitomo Chemical Provides Funds to NanoScent, Developing Diagnostic Sensor for COVID-19
- April 30, 2020
Koei Chemical Supplies Raw Materials for Remdesivir and Avigan® (KOEI CHEMICAL COMPANY, LIMITED)
- April 28, 2020
Donation of Medical Protective Equipment (Face Shields, Masks and Gowns) to Support Measures against Coronavirus Disease 2019 (COVID-19) (Sumitomo Dainippon Pharma Co., Ltd.)
- March 31, 2020
Donations to the Kitasato Institute's Project for COVID-19 for Early Identification of Therapeutic Medicine for its Treatment (Sumitomo Dainippon Pharma Co., Ltd.)
- January 29, 2020
Donations for the Prevention of Pneumonia Caused by the New Coronavirus in China (Sumitomo Dainippon Pharma Co., Ltd.)
Sumitomo Dainippon Pharma participates as a collaborator in the COVID-19 Research Database, a consortium that discusses measures against COVID-19. The consortium aims to provide researchers with free access to medical information databases in the U.S. to support research into COVID-19. Datavant, Inc., a subsidiary of our strategic partner Roivant Sciences Ltd., is also a member of the consortium. Access the URL below for details about the consortium. https://covid19researchdatabase.org/ (COVID-19 Research Database)